Correlation Between Leofoo Development and Medigen Vaccine

Can any of the company-specific risk be diversified away by investing in both Leofoo Development and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leofoo Development and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Leofoo Development Co and Medigen Vaccine Biologics, you can compare the effects of market volatilities on Leofoo Development and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leofoo Development with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leofoo Development and Medigen Vaccine.

Diversification Opportunities for Leofoo Development and Medigen Vaccine

-0.08

Correlation Coefficient

Leofoo Development  Medigen Vaccine

Good diversification

The 3 months correlation between Leofoo and Medigen is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Leofoo Development Co and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and Leofoo Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leofoo Development Co are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of Leofoo Development i.e., Leofoo Development and Medigen Vaccine go up and down completely randomly.

Pair Corralation between Leofoo Development and Medigen Vaccine

Assuming the 90 days trading horizon Leofoo Development is expected to generate 3.55 times less return on investment than Medigen Vaccine. But when comparing it to its historical volatility, Leofoo Development Co is 2.31 times less risky than Medigen Vaccine. It trades about 0.06 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  4,260  in Medigen Vaccine Biologics on October 23, 2024 and sell it today you would earn a total of  740.00  from holding Medigen Vaccine Biologics or generate 17.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Leofoo Development Co  vs.  Medigen Vaccine Biologics

Leofoo Development

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Leofoo Development Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Leofoo Development is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Vaccine Biologics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Vaccine Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Leofoo Development and Medigen Vaccine

The main advantage of trading using opposite Leofoo Development and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leofoo Development position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.

The idea behind Leofoo Development Co and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..